Trial NCT00440973

View at ClinicalTrials.gov 
Org. Study IDs: PAC IRB #03-0194-05
Secondary IDs: 16117

Last trial update was posted on 2016-03-17

MeSH Interventions

Bevacizumab Interleukin-2

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions


Stopping Reasons

contract issues

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID